期刊
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
卷 127, 期 4, 页码 354-357出版社
WILEY
DOI: 10.1111/bcpt.13428
关键词
duloxetine; genetic polymorphisms; therapeutic drug monitoring; venlafaxine